Sort   by:  
 Page size 
TranscriptomicsLeukemias of different origins
We generated MLL-AF9 mediated murine leukemias that originate either from hematopoietic stem or committed progenitors cells. The luekemia stem cell fraction in these two type of leukemias shared exactly the same immunophenotype but their genetic programs differ.
ORGANISM(S): Mus musculus 
2011-03-31 | GSE18483 | GEO
TranscriptomicsLeukemias of different origins
We generated MLL-AF9 mediated murine leukemias that originate either from hematopoietic stem or committed progenitors cells. The luekemia stem cell fraction in these two type of leukemias shared exactly the same immunophenotype but their genetic programs differ. Total RNA from HSC(KLS), CMP, MEP, an...
ORGANISM(S): Mus musculus 
2011-03-31 | E-GEOD-18483 | biostudies-arrayexpress
GenomicsMus musculus
Leukemias of different origins
PRJNA120225 | ENA
UnknownS129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INHIBITOR EMAVUSERTIB (CA-4948) AS MONOTHERAPY OR IN COMBINATION WITH AZACITIDINE OR VENETOCLAX IN RELAPSED/REFRACTORY AML OR MDS
Not available
S-EPMC9642083 | biostudies-literature
ProteomicsNCI60 proteome by PCT-SWATH - Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
We obtained quantitative analysis of the NCI-60 cell panels using pressure cycling technology (PCT) and SWATH-MS. Each cell was analyzed in duplicate. The data were analyzed using a cell line SWATH assay library and OpenSWATH, followed by SWATH-expert refinement.
ORGANISM(S): Homo sapiens (Human) 
2020-06-01 | PXD003539 | Pride
Nci-60 cell  pct  swath  breast cancer  luekemia  colon cancer  melanoma  ovarian cancer  brain tumor  renal cancer  lung cancer  prostate cancer  drug sensitivity 
Sort   by:  
 Page size